BlackRock Institutional Trust’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.48M Buy
2,139,488
+68,982
+3% +$289K ﹤0.01% 2433
2016
Q3
$9.67M Buy
2,070,506
+183,968
+10% +$1.09M ﹤0.01% 2353
2016
Q2
$12.4M Buy
1,886,538
+69,580
+4% +$492K ﹤0.01% 2160
2016
Q1
$11.6M Buy
1,816,958
+19,319
+1% +$99.1K ﹤0.01% 2167
2015
Q4
$10.8M Buy
1,797,639
+29,979
+2% +$171K ﹤0.01% 2267
2015
Q3
$10.6M Sell
1,767,660
-180,222
-9% -$1.25M ﹤0.01% 2261
2015
Q2
$13.3M Sell
1,947,882
-160,025
-8% -$1.02M ﹤0.01% 2218
2015
Q1
$12.8M Buy
2,107,907
+34,875
+2% +$232K ﹤0.01% 2229
2014
Q4
$14.4M Buy
2,073,032
+106,336
+5% +$782K ﹤0.01% 2125
2014
Q3
$16M Buy
1,966,696
+47,193
+2% +$369K ﹤0.01% 2020
2014
Q2
$15.6M Buy
1,919,503
+81,483
+4% +$618K ﹤0.01% 2130
2014
Q1
$14.4M Buy
1,838,020
+38,619
+2% +$327K ﹤0.01% 2184
2013
Q4
$15.9M Sell
1,799,401
-8,431
-0.5% -$75.3K ﹤0.01% 2109
2013
Q3
$15.2M Sell
1,807,832
-92,565
-5% -$749K ﹤0.01% 2063
2013
Q2
$14.2M Buy
+1,900,397
New +$14.6M ﹤0.01% 2067

Other funds holding SPPI

BlackRock Institutional Trust's SPPI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 3.3% in Q4 2016, buying an estimated $289K and bringing the position to 2,139,488 shares worth $9.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

BlackRock Institutional Trust first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $16M in Q3 2014. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

  • BlackRock Institutional Trust held 2,139,488 shares of Spectrum Pharmaceuticals Inc worth $9.48M as of Q4 2016.
  • BlackRock Institutional Trust bought 68,982 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $289K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2433 holding.
  • BlackRock Institutional Trust first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Spectrum Pharmaceuticals Inc position peaked at $16M in Q3 2014.
  • 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.